Immunogenicity phase II study evaluating booster capacity of nonadjuvanted AKS-452 SARS-Cov-2 RBD Fc vaccine

Authors: David G. Alleva, Eline A. Feitsma, Yester F. Janssen, Hendrikus H. Boersma, Thomas M. Lancaster, Thillainaygam Sathiyaseelan, Sylaja Murikipudi, Andrea R. Delpero, Melanie M. Scully, Ramya Ragupathy, Sravya Kotha, Jeffrey R. Haworth, Nishit J. Shah, Vidhya Rao, Shashikant Nagre, Shannon E. Ronca, Freedom M. Green, Stephen A. Shaw, Ari Aminetzah, Schelto Kruijff, Maarten Brom, Gooitzen M. van Dam, Todd C. Zion

Source: npj Vaccines, Vol 9, Iss 1, Pp 1-12 (2024)

Subject Terms: Immunologic diseases. Allergy, RC581-607, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://doaj.org/toc/2059-0105

Access URL: https://doaj.org/article/3e169ceb8cc4445682f02ab1847c3f9e

COVID-19 associated myelitis: A case series

Authors: Pravin Naphade, Sravya Kotharu, Shalesh Rohatgi, Satish Nirhale, Prajwal Rao

Source: Medical Journal of Dr. D.Y. Patil Vidyapeeth, Vol 15, Iss 7, Pp 106-109 (2022)

Subject Terms: acute transverse myelitis, covid-19, myelin associated glycoprotein, Medicine

File Description: electronic resource

Relation: http://www.mjdrdypv.org/article.asp?issn=2589-8302;year=2022;volume=15;issue=7;spage=106;epage=109;aulast=Naphade; https://doaj.org/toc/2589-8302; https://doaj.org/toc/2589-8310

Access URL: https://doaj.org/article/9f5cbea73b844adcb6c6ae4f59604618